Advanced Malignant Solid Tumors Clinical Trials

41 clinical trials for Advanced Malignant Solid Tumors across international registries, including 11 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Phase I Study of JSKN021 in Advanced Solid Tumors — RECRUITING · PHASE1
• A Study of TPD3310 in Patients With Advanced Malignant Tumors — RECRUITING · PHASE1
• N-3C01 Monotherapy and Combination With PD-(L)1 Inhibitors in Advanced Solid Tumors — RECRUITING · PHASE1
• Phase II Study of JS212/JS213 as Monotherapy and in Combination in Patients With Advanced Malignant Solid Tumors — RECRUITING · PHASE2
• A Study of FC084CSA in Combination of Tislelizumab in Patients With Advanced Malignant Solid Tumors — RECRUITING · PHASE1
• A Study of CSCJC3456 in Patients With Advanced Malignant Tumors — RECRUITING · PHASE1
• JSKN022 in Subjects With Advanced Malignant Solid Tumors — RECRUITING · PHASE1
• Using Neoantigen Peptide Vaccine/neoantigen-based DC to Treat Advanced Malignant Solid Tumors — RECRUITING · NA
• A Study of GQ1010 in Subjects With Advanced Solid Tumors — RECRUITING · PHASE1
• A Clinical Research About CD70-targeted CAR-NKT Cells Therapy in Subjects with Advanced Malignant Solid Tumors — RECRUITING · PHASE1
• A Clinical Study of 9MW2821 in Advanced Malignant Solid Tumors — RECRUITING · PHASE1
• Trial to Evaluate the Safety and Preliminary Efficacy of GEN1079 in Participants with Advanced Solid Tumors — TERMINATED · PHASE1
• Phase I Study of WJ47156 Monotherarpy and in Combination With Other Therapy in Advanced Solid Tumors — ACTIVE_NOT_RECRUITING · PHASE1
• SCTB41 Plus SCTB39G With or Without Standard Therapy in Advanced Solid Tumors — NOT_YET_RECRUITING · PHASE1
• CIB In Vivo CAR-T Lentiviral Injection in Patients With Advanced Malignant Tumors — NOT_YET_RECRUITING · PHASE1
• A Study of CS231295 in Patients With Advanced Solid Tumors — NOT_YET_RECRUITING · PHASE1
• Trial to Assess the Safety and Antitumor Activity of GEN1057 in Malignant Solid Tumors — TERMINATED · PHASE1
• A Phase I Clinical Study of AK150 in Advanced Malignant Solid Tumor — NOT_YET_RECRUITING · PHASE1
• Exploratory Clinical Study of FAP mRNA Vaccine in Patients With Advanced Malignant Solid Tumors — NOT_YET_RECRUITING · PHASE1
• A Study of Axl Inhibitor FC084CSA in Patients With Advanced Malignant Solid Tumors — COMPLETED · PHASE1
• Clinical Study of MNC-168 Enteric-coated Capsule in the Treatment of Advanced Intestinal Solid Tumor — COMPLETED · PHASE1
• A Study of HMPL-295S1 in Patients With Advanced Malignant Solid Tumors — COMPLETED · PHASE1
• A Study of HMPL-415S1 in Patients With Advanced Malignant Solid Tumors — OTHER · PHASE1
• Clinical Study of mRNA Vaccine in Patients With Advanced Malignant Solid Tumors — OTHER · NA
• A Study of MRG002 in the Treatment of Patients With HER2-expressed Advanced Malignant Solid Tumors. — OTHER · PHASE1
• Study of Challenge Meditech 082 (CM082) Tablets in Patients With Advanced Malignant Solid Tumors — OTHER · PHASE1
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Efficacy of Cisplatin Micelle Injection (HA132) in Patients With Advanced Malignant Solid Tumors — OTHER · PHASE1
• Clinical Study of HMPL-653 in Treatment of Advanced Malignant Solid Tumors and TGCT — OTHER · PHASE1
• Bioequivalency Study of CM082 Tablet in Healthy Volunteers — COMPLETED · PHASE1
• Safety, Tolerability and Pharmacokinetics Characteristics of Recombinant Oncolytic Vaccinia Virus Injection T601 as a Single Drug or in Combination With Oral Flucytosine (5-FC), in Patients With Advanced Malignant Solid Tumors — OTHER · PHASE1
• A Study to Investigate the Food Effect on the Pharmacokinetics of CM082 Tablet in Chinese Healthy Volunteers — COMPLETED · PHASE1
• A Dose Escalation Study of MLN7243 (TAK-243) in Adult Participants With Advanced Solid Tumors — TERMINATED · PHASE1
• A Study Of Neratinib (HKI-272) And Capecitabine In Japanese With Solid Tumor — COMPLETED · PHASE1
• Study Evaluating Safety And Tolerability, Solid Tumor — COMPLETED · PHASE1
• Study of PKI-179 Administered Orally to Subjects With Solid Tumors — WITHDRAWN · PHASE1
• Study Evaluating Neratinib (HKI-272) In Combination With Vinorelbine In Subjects With Solid Tumors And Metastatic Breast Cancer — COMPLETED · PHASE1
• A Phase 1/2 Study of HKI-272 (Neratinib) in Combination With Paclitaxel (Taxol) in Subjects With Solid Tumors and Breast Cancer — COMPLETED · PHASE1
• Study Evaluating Neratinib In Combination With Vinorelbine In Subjects With Advanced Or Metastatic Solid Tumors — COMPLETED · PHASE1
• A Study To Test The Impact Of PF- 00299804 On How The Body Handles Dextromethorphan In Cancer Patients — COMPLETED · PHASE1
• The Study of Targeted NY-ESO-1 T Cell Receptor (TCR) Genetic Modified Autologous T Cells Treatment of Advanced Solid Tumors — OTHER · NA
• Trial of PM02734 Administered in Combination With Erlotinib in Patients With Advanced Malignant Solid Tumors — COMPLETED · PHASE1

Refine this search